🇱🇹

Pharmaceutical Products from Lithuania Tariff: 15% (2026)

Tariff Rate Breakdown

15%

EU Deal Ceiling

15%

Effective Rate

Pharmaceutical Products from Lithuania represent an important segment of bilateral trade, with approximately $1.5B in total bilateral trade.

The current tariff framework for pharmaceutical products from Lithuania reflects the EU-US trade deal effective July 1, 2026: a flat 15% all-inclusive ceiling with no stacking (MFN rates of 15%+ pay MFN only). It caps a volatile 18 months — IEEPA rates struck down by the Supreme Court on February 20, 2026, then a 10% Section 122 bridge from February 24, then the deal rate.

Unlike the Section 301 forced-labor tariff that replaced Section 122 for non-EU countries on July 24, 2026, the EU deal's 15% ceiling has no built-in sunset. The next scheduled change comes September 1, 2026, when aircraft and aircraft parts, generic pharmaceuticals plus their ingredients and precursors, and unavailable natural resources (such as cork) from the EU revert to MFN-only rates.

Pharmaceutical Products (HTS Chapter 30) generally enter duty-free at the MFN level, so the EU deal's flat 15% is the entire duty burden. No additional Section 232 or Section 301 surcharges apply to most products in this category from Lithuania.

Key products in HTS Chapter 30 imported from Lithuania include Vaccines, Antibiotics, Insulin, Bandages, Diagnostic reagents, and Blood products.

Common Products in Chapter 30

VaccinesAntibioticsInsulinBandagesDiagnostic reagentsBlood productsPharmaceutical dosage formsFirst-aid kits

Calculate Your Import Duty

Use our tariff calculator to estimate the exact duty on your pharmaceutical products imports from Lithuania.

Open Tariff Calculator

Frequently Asked Questions

What is the current tariff rate on pharmaceutical products from Lithuania?

As of July 2026, pharmaceutical products from Lithuania fall under the EU-US trade deal's 15% all-inclusive ceiling (effective July 1, 2026). Nothing stacks on top — goods with MFN rates below 15% pay 15% total, and goods with MFN rates of 15% or higher pay MFN only. The effective rate is about 15% on the most-affected products.

Will the tariff on pharmaceutical products from Lithuania change?

Unlike the Section 301 forced-labor tariff on non-EU countries (which replaced the flat 10% Section 122 rate on July 24, 2026), the EU deal's 15% ceiling has no built-in expiration. The next scheduled change is September 1, 2026, when EU aircraft and aircraft parts, generic pharmaceuticals plus their ingredients and precursors, and unavailable natural resources revert to MFN-only rates.

How did 2026's tariff changes affect pharmaceutical products imports from Lithuania?

Three regimes in one year: the Supreme Court struck down IEEPA reciprocal tariffs on February 20, 2026; a 10% Section 122 tariff bridged February 24 through June 30; and the EU-US trade deal's 15% all-inclusive ceiling took effect July 1, 2026. In exchange, the EU eliminated its duties on US industrial goods the same day.